gci

RoundTable Acquisition of Revision-Goodier Promises New Skin Care Launches

Contact Author
Close
Fill out my online form.

The Revision-Goodier acquisition will yield new launches and spur acquisitions of brands to build out the portfolio.

Guess what? Private equity strikes again in beauty. RoundTable Healthcare Partners has invested in Revision Skincare LLC, a physician-direct brand sold exclusively through dermatologists, plastic surgeons and other specialists (brand names incldue: Nectifirm, Intellishade and Teamine), and Goodier Cosmetics LLC, a niche topical personal care and OTC pharmaceutical product manufacturer.

Financial terms of the transaction were not disclosed. Revision-Goodier is the third investment from RoundTable's $650 million Fund IV.

Revision-Goodier founders John Muller and Rob Muller "will retain a significant ownership stake in the company" and will continue on in their respective roles as CEO and COO.

"We look forward to expanding Revision's product portfolio through internal product development..."

"We look forward to expanding Revision's product portfolio through internal product development and via product acquisitions, both for assets sold exclusively through the professional channel as well as over-the-counter skincare products."

"We are very excited to partner with the Mullers," said Pierre Fréchette, senior operating partner at RoundTable. "They have built a strong presence in the physician direct dispense market and have done a remarkable job serving skincare professionals. We look forward to expanding Revision's product portfolio through internal product development and via product acquisitions, both for assets sold exclusively through the professional channel as well as over-the-counter skincare products."

"Revision-Goodier is our third platform investment in the dermatology market in the last five years," said David Koo, senior partner at RoundTable. "Our familiarity with topical contract development and manufacturing organizations will allow us to play a value-added role in supporting the growth of Goodier and their clients," added .

"RoundTable represents the ideal partner for Revision-Goodier," said John Muller. "Their extensive experience in the dermatology pharmaceutical marketplace provides us with the needed resources to continue our growth trajectory."

"We would like to thank our employees for helping us build such a strategically valuable platform company," said Rob Muller. "We are excited about the company's future in partnership with RoundTable."

 

Related Content